Nalaganje...

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Patients with non-small cell lung cancer (NSCLC) who harbor anaplastic lymphoma kinase (ALK) gene rearrangements can derive significant clinical benefit from ALK tyrosine kinase inhibitor. Accurate patient identification is absolutely crucial for successful using ALK inhibitor treatment. However, lu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Lung Cancer Res
Main Authors: Kim, Hyojin, Chung, Jin-Haeng
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384218/
https://ncbi.nlm.nih.gov/pubmed/25870797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.12.02
Oznake: Označite
Brez oznak, prvi označite!